218 related articles for article (PubMed ID: 24868582)
1. Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study.
Parareda A; Català J; Carcaboso AM; Sola T; Cruz O; Díaz J; Salvador H; de Torres C; Álvarez-Sampons A; Suñol M; Vinent J; Guimaraens L; Prat J; Mora J
Acta Ophthalmol; 2014 May; 92(3):209-15. PubMed ID: 24868582
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
3. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
[TBL] [Abstract][Full Text] [Related]
4. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
6. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
8. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
[TBL] [Abstract][Full Text] [Related]
10. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
11. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
12. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study.
Lumbroso-Le Rouic L; Blanc R; Saint Martin C; Savignoni A; Brisse HJ; Pierrat N; Lévy-Gabriel C; Matet A; Doz F; Aerts I; Cassoux N
Ophthalmol Retina; 2021 Aug; 5(8):e30-e37. PubMed ID: 34000459
[TBL] [Abstract][Full Text] [Related]
13. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
15. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
17. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
18. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
Ong SJ; Chao AN; Wong HF; Liou KL; Kao LY
Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
[TBL] [Abstract][Full Text] [Related]
19. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
20. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Suzuki S; Yamane T; Mohri M; Kaneko A
Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
